Eversept Partners, LP
NEW YORK, NY · CIK 1697013 · 13F filing filed 2025-05-15
SEC-registered investment adviser since 2017 · limited partnership
- Assets managed$2.7bn
- Staff10 · 5 in investment roles
- Main clients (by assets)Private funds 99%, Mutual funds and ETFs 1%
- Private funds3 (3 hedge) · $2.3bn gross assets
- Websiteeversept.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityEVERSEPT PARTNERS, L.P. (US)
- Kindhedge funds, futures
- Others nearbyNew York, NY, San Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 4 |
| San Francisco, CAUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 0 call positions (— notional), 2 put positions ($101.0m notional) – listed below, not included above.
Holdings, Q1 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| NATERA INC NTRA | $126.4m14.30% | Added +17.0k |
| GSK PLC GSK | $101.6m11.50% | Reduced -1.0m |
| HCA HEALTHCARE INC HCA | $52.7m5.96% | Reduced -23.3k |
| SYNDAX PHARMACEUTICALS INC SNDX | $51.7m5.86% | Added +3.9m |
| VERA THERAPEUTICS INC VERA | $45.6m5.16% | Added +298.8k |
| REVVITY INC RVTY | $31.6m3.58% | Reduced -93.4k |
| HEALTHEQUITY INC HQY | $31.1m3.52% | Reduced -34.7k |
| INSPIRE MED SYS INC INSP | $29.7m3.36% | Reduced -107.9k |
| PROTAGONIST THERAPEUTICS INC PTGX | $26.5m2.99% | Reduced -131.7k |
| COMMUNITY HEALTH SYS INC NEW CYH | $22.8m2.58% | Added +5.6m |
| ZIMVIE INC ZIMV | $22.5m2.54% | Added +8.6k |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $21.7m2.45% | Reduced -831.4k |
| VAXCYTE INC PCVX | $21.0m2.38% | Added +429.5k |
| BRUKER CORP BRKR | $20.8m2.36% | Added +264.3k |
| CENTENE CORP DEL CNC | $20.7m2.34% | Added +151.8k |
| VIRIDIAN THERAPEUTICS INC VRDN | $18.6m2.10% | Added +597.7k |
| NEUROCRINE BIOSCIENCES INC NBIX | $18.5m2.09% | New |
| UNITED THERAPEUTICS CORP DEL UTHR | $17.7m2.01% | Added +13.8k |
| BIO-TECHNE CORP TECH | $16.4m1.86% | Reduced -19.2k |
| BIOCRYST PHARMACEUTICALS INC BCRX | $16.3m1.84% | Added +192.1k |
| GLAUKOS CORP GKOS | $15.6m1.77% | New |
| IONIS PHARMACEUTICALS INC IONS | $15.6m1.77% | Added +302.1k |
| TRAVERE THERAPEUTICS INC TVTX | $14.6m1.66% | Added +326.0k |
| GLOBUS MED INC GMED | $14.1m1.60% | New |
| CELLDEX THERAPEUTICS INC NEW CLDX | $12.6m1.43% | Reduced -23.3k |
| INVESCO QQQ TR QQQ | $11.3m1.27% | New |
| ALIGN TECHNOLOGY INC ALGN | $7.8m0.89% | New |
| TELEFLEX INCORPORATED TFX | $7.8m0.89% | Reduced -5.1k |
| MOLINA HEALTHCARE INC MOH | $7.8m0.88% | New |
| HUMANA INC HUM | $7.4m0.84% | Added +5.3k |
| ELEVANCE HEALTH INC ELV | $6.8m0.77% | Reduced -13.5k |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $5.8m0.65% | Added +5.6k |
| GOSSAMER BIO INC GOSS | $4.3m0.49% | Reduced -1.1m |
| ZENAS BIOPHARMA INC ZBIO | $3.5m0.40% | Added +273.5k |
| MANNKIND CORP MNKD | $3.5m0.40% | Reduced -213.3k |
| MERUS N V MRUS | $3.0m0.33% | Added +2.1k |
| REPLIGEN CORP RGEN | $2.3m0.27% | Reduced -35.6k |
| NOVAVAX INC NVAX | $2.3m0.27% | New |
| LIQUIDIA CORPORATION LQDA | $2.2m0.25% | Reduced -420.8k |
| FORTREA HLDGS INC FTRE | $2.2m0.25% | Reduced -108.5k |
| 89BIO INC ETNB | $2.2m0.25% | New |
| MARAVAI LIFESCIENCES HLDGS I MRVI | $2.1m0.24% | New |
| AVANTOR INC AVTR | $2.0m0.23% | Reduced -45.5k |
| ICON PLC ICLR | $1.9m0.21% | Reduced -8.4k |
| INFLARX NV IFRX | $1.7m0.19% | Added +1.2m |
| AMARIN CORP PLC SPONS ADR NEW | $1.5m0.17% | Added +1.9m |
| SUTRO BIOPHARMA INC COM | $1.5m0.17% | Added +1.6m |
| ITEOS THERAPEUTICS INC ITOS | $1.3m0.15% | Unchanged |
| KARYOPHARM THERAPEUTICS INC KPTI | $961.8k0.11% | New |
| XOMA ROYALTY CORPORATION XOMA | $897.2k0.10% | Reduced -50.4k |
| PUMA BIOTECHNOLOGY INC PBYI | $816.3k0.09% | Reduced -720.3k |
| ALECTOR INC ALEC | $759.4k0.09% | Added +417.3k |
| EHEALTH INC EHTH | $596.0k0.07% | New |
| AUTOLUS THERAPEUTICS PLC AUTL | $533.1k0.06% | Added +245.1k |
| AC IMMUNE SA ACIU | $188.4k0.02% | New |
Sold out since Q4 2024
| Security | Value then |
|---|---|
| VIATRIS INC VTRS | $15.8m1.3m shares |
| EDWARDS LIFESCIENCES CORP EW | $12.6m170.7k shares |
| DEXCOM INC DXCM | $11.6m148.7k shares |
| GUARDANT HEALTH INC GH | $8.4m276.0k shares |
| ASTRAZENECA PLC | $6.7m102.7k shares |
| MEDPACE HLDGS INC MEDP | $6.3m19.0k shares |
| XENON PHARMACEUTICALS INC XENE | $6.1m155.5k shares |
| HENRY SCHEIN INC HSIC | $5.6m80.3k shares |
| DANAHER CORPORATION DHR | $5.1m22.2k shares |
| PATTERSON COS INC PDCO | $4.5m146.1k shares |
| EVOLUS INC EOLS | $4.2m383.0k shares |
| SUPERNUS PHARMACEUTICALS INC SUPN | $3.8m105.6k shares |
| 2SEVENTY BIO INC TSVT | $3.0m1.0m shares |
| MEREO BIOPHARMA GROUP PLC MREO | $2.7m777.9k shares |
| ZAI LAB LTD ZLAB | $2.7m102.9k shares |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $2.7m191.2k shares |
| DENTSPLY SIRONA INC XRAY | $2.7m139.7k shares |
| KARYOPHARM THERAPEUTICS INC | $1.4m2.1m shares |
| ABSCI CORPORATION ABSI | $522.6k199.5k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| INVESCO QQQ TR QQQ · Put | $58.0m123.6k shares | Reduced |
| SPDR S&P 500 ETF TR SPY · Put | $43.0m76.9k shares | Added |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 | 5.7%≈ $26.5m |